International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2023 - Volume 27, Number 1
View All Articles in Issue

Page(s): 52

Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: dapsone, formulations, oral suspensions, leprosy, pneumocystis pneumonia, malaria, dermatoses

Related Categories: DERMATOLOGY, EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 52
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 502
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 236
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Dapsone 2-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 300
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 51
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 58
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2022 Pg. 56
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	May/Jun 2022 Pg. 241
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 57
Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension Allen Loyd V Jr	May/Jun 2020 Pg. 233
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 51
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Allen Loyd V Jr	Jul/Aug 2020 Pg. 316
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D	May/Jun 2003 Pg. 233-239
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension Allen Loyd V Jr	Jul/Aug 2019 Pg. 314
Return to Top